Hepatitis E: Are rheumatic patients at risk?

Journal of Rheumatology

Volumn 40, Issue 1, 2013, Pages 99-

  Roux, Christian H ^a   Anty, Rodolphe ^a   Patouraux, Stephanie ^b   Euller Ziegler, Liana ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b PASTEUR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; METHOTREXATE; METRONIDAZOLE; RIBAVIRIN; RITUXIMAB; VIRUS RNA;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADULT; ANOREXIA; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; EOSINOPHILIA; FIBROSIS; GENOTYPE; HEPATITIS E; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; LETTER; LIVER BIOPSY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT DURATION;

ANTIVIRAL AGENTS; ARTHRITIS, RHEUMATOID; HEPATITIS E; HUMANS; MALE; MIDDLE AGED; RIBAVIRIN; RISK FACTORS; TREATMENT OUTCOME;

EID: 84871867553     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120599     Document Type: Letter

References (10)

1. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012;379:2477-88.
2. Teshale EH, Hu DJ. Hepatitis E: Epidemiology and prevention. World J Hepatol 2011;3:285-91.
3. Boutrouille A, Bakkali-Kassimi L, Crucière C, Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007;45:2009-10. (Pubitemid 46933947)
4. Renou C, Moreau X, Pariente A, Cadranel JF, Maringe E, Morin T, et al. A national survey of acute hepatitis E in France. Aliment Pharmacol Ther 2008;27:1086-93. (Pubitemid 351614889)
5. Rafailidis PI, Kakisi OK, Vardakas K, Falagas ME. Infectious complications of monoclonal antibodies used in cancer therapy: A systematic review of the evidence from randomized controlled trials. Cancer 2007;109:2182-9. (Pubitemid 46805005)
6. Spina M, Jaeger U, Sparano JA, Talamini R, Simonelli C, Michieli M, et al. Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV associated non-Hodgkin lymphoma: Pooled results from 3 phase 2 trials. Blood 2005;105:1891-7. (Pubitemid 40731769)
7. Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, et al. Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 2007;48:1307-12. (Pubitemid 47079357)
8. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009;150:430-1.
9. Mansuy JM, Peron JM, Abravanel Poirson H, Dubois M, Miedouge M, Vischi F, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004;74:419-24. (Pubitemid 39281640)
10. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010;202:825-34.